Abbott to Present at J.P. Morgan Healthcare Conference

ABBOTT PARK, Ill., Dec. 19, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the 32nd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2014. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a formal presentation on the company at noon CST.

A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at www.abbottinvestor.com. An archived edition of the presentation will be available later that day.

About Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

 

SOURCE Abbott

Suggested Articles

If Pfizer wants Lorbrena to be a true follow-up to Xalkori, it has to win a first-line OK in ALK-positive lung cancer. And it just got closer.

Eylea sales dropped 4% to $1.11 billion amid the pandemic, but still beat expectations. And meanwhile, Regeneron's COVID antibody is advancing.

Johnson & Johnson inked a $10-per-dose vaccine supply deal with the U.S. for 100 million initial doses, with 200 million more available down the line.